Cargando…

To Know or Not to Know: Ethical Issues Related to Early Diagnosis of Alzheimer's Disease

In Alzheimer's disease (AD), pathological processes start in the brain long before clinical dementia. Biomarkers reflecting brain alterations may therefore indicate disease at an early stage, enabling early diagnosis. This raises several ethical questions and the potential benefits of early dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattsson, Niklas, Brax, David, Zetterberg, Henrik
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925376/ https://www.ncbi.nlm.nih.gov/pubmed/20798843 http://dx.doi.org/10.4061/2010/841941

Ejemplares similares

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Ethical issues in early diagnosis and prevention of Alzheimer disease
por: Whitehouse, Peter J
Publicado: (2019)

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Biomarkers for Microglial Activation in Alzheimer's Disease
por: Lautner, Ronald, et al.
Publicado: (2011)

Authors should know the ethical rules of publication
por: Yousef Khan, Fahmi
Publicado: (2010)

Ethical, Legal, and Social Issues of the Human Genome Project: What to Do with What We Know.
por: Pellerin, C
Publicado: (1994)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

What pharmacy practitioners need to know about ethics in scientific publishing
por: Zunic, Lejla, et al.
Publicado: (2014)

I know that I know. But do I know that I do not know?
por: Polyanskaya, Leona
Publicado: (2023)

What do patients know about healthcare-associated infections? What do they want to know? Ethical evaluation
por: Sahiner, Pervin
Publicado: (2023)

Publication ethics – What do we need to know?
por: Mills, Michael
Publicado: (2019)

The right not to know and the obligation to know
por: Davies, Ben
Publicado: (2020)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
por: Cullen, Nicholas C., et al.
Publicado: (2020)

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
por: Palmqvist, Sebastian, et al.
Publicado: (2015)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

Wants to Know You Know
Publicado: (1885)

Want to Know, You Know
por: Kraft, Frank
Publicado: (1890)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Disclosure Dilemmas: Ethics of Genetic Prognosis after the 'Right to Know/Not to Know' Debate Christoph Rehmann-Sutter & Hansjakob Muller (eds.) Ashgate 2009
por: Carrieri, Daniele
Publicado: (2010)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne, Declan, et al.
Publicado: (2019)

The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
por: Chandra, Sidhanth, et al.
Publicado: (2023)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease
por: Wikler, Elizabeth M, et al.
Publicado: (2013)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Chinese pediatric researchers need to know more about ethics
por: Peng, Xiaoxia
Publicado: (2018)

COVID-19 Ethics: What Interventional Radiologists Need to Know
por: Shnayder, Michelle M., et al.
Publicado: (2020)

It takes a pirate to know one: ethical hackers for healthcare cybersecurity
por: Lorenzini, Giorgia, et al.
Publicado: (2022)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
por: Rudnicka-Drożak, Ewa, et al.
Publicado: (2023)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Hypospadias, all there is to know
por: van der Horst, H. J. R., et al.
Publicado: (2017)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know
por: Petrides, Petro E.
Publicado: (2022)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3em2vfg83haehjseqhotm3n6q7